- The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany
-
Fick EM, Katalinic , Waldmann A
- KMID: 2403393
- Cancer Res Treat.
- 2015 Oct;47(4):747-756.
- doi: 10.4143/crt.2014.099
PURPOSE: The aim of this cross-sectional health care study (use of bisphosphonates in primary tumors of the mammae, EBisMa) is to determine how often bisphosphonate medication is used in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute
-
Choi Y, Keam B, Kim TM, Lee SH, Kim DW, Heo DS
- KMID: 2403371
- Cancer Res Treat.
- 2015 Oct;47(4):555-563.
- doi: 10.4143/crt.2014.200
PURPOSE: The purpose of this study was to investigate and compare cancer treatment near the end-of-life (EOL) over a 10-year period. MATERIALS AND METHODS: Patients with advanced solid cancer at Seoul... -
- CITED
-
- Close
- SHARE
-
- Close
- Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report
-
Woo HS, Lee KH, Yoon PH, Kim SJ, Park I, Kim YS, Ahn HK, Hong J, Shin DB, Sym SJ
- KMID: 2403417
- Cancer Res Treat.
- 2015 Oct;47(4):949-953.
- doi: 10.4143/crt.2014.052
Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal cancer treatment. Although myelosuppression is the most common cause of oxaliplatin-induced thrombocytopenia, rare cases of oxaliplatin-induced immune-mediated thrombocytopenia... -
- CITED
-
- Close
- SHARE
-
- Close
- Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned
-
Lee DH, Srimuninnimit V, Cheng R, Wang X, Orlando M
- KMID: 2403370
- Cancer Res Treat.
- 2015 Oct;47(4):549-554.
- doi: 10.4143/crt.2014.362
Advances in oncology research have led to identification of tumor-specific biomarkers, some of which are important predictive indicators and ideal targets for novel therapeutics. One such biomarker in non-small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database
-
Kang S, Kim HS, Choi ES, Han I
- KMID: 2403374
- Cancer Res Treat.
- 2015 Oct;47(4):575-582.
- doi: 10.4143/crt.2014.047
PURPOSE: We conducted a nationwide study to assess the incidence and treatment patterns of extremity soft tissue sarcoma (STS) in South Korea. MATERIALS AND METHODS: The nationwide incidence and treatment patterns... -
- CITED
-
- Close
- SHARE
-
- Close
- The Economic Burden of Breast Cancer in Korea from 2007-2010
-
Kim YA, Oh IH, Yoon SJ, Kim HJ, Seo HY, Kim EJ, Lee YH, Jung JH
- KMID: 2403375
- Cancer Res Treat.
- 2015 Oct;47(4):583-590.
- doi: 10.4143/crt.2014.143
PURPOSE: This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. MATERIALS AND METHODS: This study used a prevalence-based approach to estimate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor
-
Cho JH, Lim JY, Choi AR, Choi SM, Kim JW, Choi SH, Cho JY
- KMID: 2403388
- Cancer Res Treat.
- 2015 Oct;47(4):697-705.
- doi: 10.4143/crt.2013.175
PURPOSE: This study was conducted to validate the survival benefit of metastasectomy plus chemotherapy over chemotherapy alone for treatment of Krukenberg tumors from gastric cancer and to identify prognostic factors... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey
-
Shin DW, Cho J, Yang HK, Kim SY, Lee SH, Suh B, Shin HY, Lee HJ, Kim DG, Park JH
- KMID: 2403376
- Cancer Res Treat.
- 2015 Oct;47(4):591-599.
- doi: 10.4143/crt.2014.086
PURPOSE: In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies.... -
- CITED
-
- Close
- SHARE
-
- Close
- Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
-
Oh DY, Lee SH, Han SW, Kim MJ, Kim TM, Kim TY, Heo DS, Yuasa M, Yanagihara Y, Bang YJ
- KMID: 2403378
- Cancer Res Treat.
- 2015 Oct;47(4):607-615.
- doi: 10.4143/crt.2014.249
PURPOSE: OPB-31121 is an oral STAT3 inhibitor with a good preclinical antitumor activity. This phase I dose-escalation study of OPB-31121 was conducted to determine maximum-tolerated dose (MTD), safety, pharmacokinetics, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
-
Hong JH, Lee SE, Choi SY, Kim SH, Jang EJ, Bang JH, Park JE, Jeon HR, Oh YJ, Yi JE, Jung HO, Youn HJ, Kim DW
- KMID: 2403415
- Cancer Res Treat.
- 2015 Oct;47(4):937-942.
- doi: 10.4143/crt.2013.155
We describe two cases of pulmonary arterial hypertension (PAH) that occurred under dasatinib treatment and were resolved after dasatinib discontinuation. Two patients with chronic phase chronic myeloid leukemia (CML) were... -
- CITED
-
- Close
- SHARE
-
- Close
- APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer
-
Shin JH, Choi S, Lee YR, Park MS, Na YG, Irani K, Lee SD, Park JB, Kim JM, Lim JS, Jeon BH
- KMID: 2403402
- Cancer Res Treat.
- 2015 Oct;47(4):823-833.
- doi: 10.4143/crt.2014.074
PURPOSE: Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that shows elevated expression in a number of cancers. We attempted to determine whether serum APE1/Ref-1 is elevated in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologists' Experience with Patients with Second Primary Cancer and the Attitudes toward Second Primary Cancer Screening: A Nationwide Survey
-
Shin DW, Cho J, Yang HK, Kim SY, Park B, Cho B, Kim HJ, Lee YJ, Jo DY, Park JH
- KMID: 2403377
- Cancer Res Treat.
- 2015 Oct;47(4):600-606.
- doi: 10.4143/crt.2014.162
PURPOSE: Screening for second primary cancer (SPC) is one of the key components to survivorship care. We aim to evaluate the oncologists' experience with SPCs and assess the current practice,... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Interval for Repeated Gastric Cancer Screening in Normal-Risk Healthy Korean Adults: A Retrospective Cohort Study
-
Bae JM, Shin SY, Kim EH
- KMID: 2403372
- Cancer Res Treat.
- 2015 Oct;47(4):564-568.
- doi: 10.4143/crt.2014.098
PURPOSE: This retrospective cohort study was conducted to estimate the optimal interval for gastric cancer screening in Korean adults with initial negative screening results. MATERIALS AND METHODS: This study consisted of... -
- CITED
-
- Close
- SHARE
-
- Close
- Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009
-
Shin SH, Jung KW, Ha J, Lee SH, Won YJ, Yoo H
- KMID: 2403373
- Cancer Res Treat.
- 2015 Oct;47(4):569-574.
- doi: 10.4143/crt.2014.085
PURPOSE: Primary central nervous system lymphoma (PCNSL) is an uncommon brain tumor accounting for 2%-5% of all primary brain tumors. Few population-based analyses of survival for patients with PCNSL have... -
- CITED
-
- Close
- SHARE
-
- Close
- Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography
-
Ozturk H
- KMID: 2403403
- Cancer Res Treat.
- 2015 Oct;47(4):834-843.
- doi: 10.4143/crt.2014.157
PURPOSE: The purpose of this study was to retrospectively investigate the contribution of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) to detection of metastatic bladder cancer. MATERIALS AND METHODS: The present study included... -
- CITED
-
- Close
- SHARE
-
- Close
- Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
-
Wu SG, Li Q, Zhou J, Sun JY, Li FY, Lin Q, Lin HX, Gaun XX, He ZY
- KMID: 2403394
- Cancer Res Treat.
- 2015 Oct;47(4):757-764.
- doi: 10.4143/crt.2014.039
PURPOSE: This study was conducted to investigate the prognostic value of lymph node ratio (LNR) in stage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy. MATERIALS AND METHODS: Clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of Platinum/Vinorelbine as More Than Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer
-
Song IC, Lee HJ, Yang YJ, Choi YS, Ryu HW, Lee MW, Moon JY, Jo DY, Kim S, Yun HJ
- KMID: 2403381
- Cancer Res Treat.
- 2015 Oct;47(4):638-644.
- doi: 10.4143/crt.2014.316
PURPOSE: There is no regimen that is strongly recommended for more than second-line treatment. We investigated the efficacy and safety of platinum/vinorelbine as more than second-line treatment. MATERIALS AND METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure
-
Lim YJ, Wu HG, Kwon TK, Hah JH, Sung MW, Kim KH, Park CI
- KMID: 2403406
- Cancer Res Treat.
- 2015 Oct;47(4):862-870.
- doi: 10.4143/crt.2014.203
PURPOSE: This study evaluates the long-term results of definitive radiotherapy (RT) for early glottic cancer. Clinical and treatment factors related to local control and patterns of failure are analyzed. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Outcome of Chondrosarcoma: A Single Institutional Experience
-
Bindiganavile S, Han I, Yun JY, Kim HS
- KMID: 2403410
- Cancer Res Treat.
- 2015 Oct;47(4):897-903.
- doi: 10.4143/crt.2014.135
PURPOSE: The prognostic factors of chondrosarcoma remain uncertain as only a few large studies with long-term follow-up have been reported. The aim of this study was to analyze oncological outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
-
Kim ST, Chang WJ, Jin L, Sung JS, Choi YJ, Kim YH
- KMID: 2403399
- Cancer Res Treat.
- 2015 Oct;47(4):796-803.
- doi: 10.4143/crt.2014.106
PURPOSE: KRAS mutations have been used widely as prognostic or predictive marker in patients with advanced colorectal cancer (CRC). However, it may be difficult to obtain a tumor tissue for... -
- CITED
-
- Close
- SHARE
-
- Close
